Monotard was Novo Nordisk's Euro brand name for their U100 lente-type insulin which is intermediate-acting. As of early 2006, this insulin was discontinued. It was known asNovolin L in North America; Eli Lilly made a comparable product, Humulin L, discontinued in the EU/UK in July 2004, also discontinued in North America in July 2005. Like all Lente insulins, regardless of species or strength, Monotard was a suspension of crystalline (ultralente) and amorphous (semilente) insulin in a ratio of 7 crystalline parts to 3 amorphous parts.
| Attributes | Values |
|---|---|
| rdfs:label |
|
| rdfs:comment |
|
| Strength |
|
| openedlife |
|
| penlife |
|
| dogaction |
|
| handlingnotes |
|
| mfg | |
| shelflife |
|
| cloudyorsoluble |
|
| cataction |
|
| generic | |
| dcterms:subject | |
| Origin | |
| Name |
|
| Similar | |
| dbkwik:petdiabetes...iPageUsesTemplate | |
| Line | |
| Aliases | |
| fgcolor |
|
| BGCOLOR |
|
| Action | |
| Suspension | |
| abstract |
|
| is Aliases of |